UNSPSC 51151668: Trimebutine
Commodity
Code facts
- Part of
-
-
51000000
-
51150000
- 51151600
-
51150000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51151668
| NIGP code |
|---|
| 26912 Autonomic Drugs |
Definition
This classification denotes an opioid receptor agonist with the molecular formula C22H29NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QZ1OJ92E5R, chemically known as 3,4,5-trimethoxybenzoic acid 2-(dimethylamino)-2-phenylbutyl ester but generally known as trimebutine, which bears US NIH Compound Identifier 5573. European Medicines Agency schedules Trimebutine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11299MIG.
Read the full definition
The term TRIMEBUTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules trimebutine in its Anatomical Therapeutic Chemical (ATC) Classification. TRIMEBUTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trimebutine under HS 29221980 and SITC 51461. As of Q4 2014, TRIMEBUTINE remains the US FDA Preferred Term for this commodity.
Trimebutine bears US NLM identifiers UMLS ID C0041023 and NCI Concept Code C80588. SMILES: O(CC(N(C)C)(CC)C1CCCCC1)C(=O)C1CC(OC)C(OC)C(OC)C1.
About UNSPSC 51151668
UNSPSC 51151668 Trimebutine is a Commodity code that in recent state and local procurement does not show activity aligned with its nominal pharmaceutical scope. The single recent opportunity tagged to this code—Seminole County, Florida's IFB60459723LAS—solicits Naloxone and Safe Drug Deactivation Systems, not Trimebutine. The mismatch suggests the code is either incorrectly applied to this procurement or carries limited relevance to current state and local buying patterns in this product family. Seminole County is the sole issuing body represented in recent postings under this code.
Seminole County, Florida remains the only jurisdiction with a recent documented opportunity. The IFB, posted June 30, 2026 with a response deadline of July 26, 2023, seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually on a two-year contract with a one-year renewal option, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Vendors must include all shipping and delivery costs in their proposal and comply with E-Verify, drug-free workplace certification, and insurance requirements including workers' compensation and commercial general liability. The contract carries a three-month probationary termination clause and potential FEMA funding, which introduces federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. This code shows no other recent state or local opportunities and appears to have minimal current procurement activity in the broader state and local market.
Quick answers
What is UNSPSC 51151668?
UNSPSC 51151668 is Trimebutine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51151668?
UNSPSC 51151668 maps to 1 NIGP code, 26912 Autonomic Drugs.
On GovTribe
See everything under UNSPSC 51151668
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code